المؤلفون: Lipka AF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Groene Hart Hospital, Gouda, The Netherlands. Electronic address: a.f.lipka@lumc.nl., Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Handbook of clinical neurology [Handb Clin Neurol] 2024; Vol. 200, pp. 307-325.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0166161 Publication Model: Print Cited Medium: Internet ISSN: 0072-9752 (Print) Linking ISSN: 00729752 NLM ISO Abbreviation: Handb Clin Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Lambert-Eaton Myasthenic Syndrome*/diagnosis , Lambert-Eaton Myasthenic Syndrome*/therapy , Autonomic Nervous System Diseases*, Humans ; Autoantibodies ; Autonomic Nervous System ; Muscle Weakness/complications

المؤلفون: Vergoossen DLE; Department of Human Genetics, Leiden University Medical Centre LUMC, Einthovenweg 20, 2300 RC Leiden, the Netherlands., Ruiter AM; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Keene KR; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Niks EH; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Tannemaat MR; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Strijbos E; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Lipka AF; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., van der Zijde ECJ; Willem-Alexander Children's Hospital, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., van Tol MJD; Willem-Alexander Children's Hospital, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Bakker JA; Department of Clinical Chemistry, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Wevers BA; Department of Clinical Chemistry, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Westerberg E; Clinical Neurophysiology, Department of Medical Sciences, Uppsala University, Akademiska sjukhuset, Ingång 85, 3rd floor, 751 85 Uppsala, Sweden., Borges LS; Department of Neurology, University of California Davis, 1515 Newton Court, Davis, CA 95618, USA., Tong OC; Department of Neurology, University of California Davis, 1515 Newton Court, Davis, CA 95618, USA., Richman DP; Department of Neurology, University of California Davis, 1515 Newton Court, Davis, CA 95618, USA., Illa I; Neuromuscular diseases Neurology department, Hospital Sant Pau UAB, Avenida Pare Claret N° 167, Barcelona 08025, Spain., Punga AR; Clinical Neurophysiology, Department of Medical Sciences, Uppsala University, Akademiska sjukhuset, Ingång 85, 3rd floor, 751 85 Uppsala, Sweden., Evoli A; Department of Neurology, Università Cattolica del Sacro Cuore, Largo A. Gemelli 1, 00168 Rome, Italy., van der Maarel SM; Department of Human Genetics, Leiden University Medical Centre LUMC, Einthovenweg 20, 2300 RC Leiden, the Netherlands., Verschuuren JJ; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Huijbers MG; Department of Human Genetics, Leiden University Medical Centre LUMC, Einthovenweg 20, 2300 RC Leiden, the Netherlands; Department of Neurology, Leiden University Medical Centre LUMC, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Electronic address: M.G.M.Huijbers@lumc.nl.

المصدر: Journal of neuroimmunology [J Neuroimmunol] 2022 Dec 15; Vol. 373, pp. 577978. Date of Electronic Publication: 2022 Oct 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 8109498 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8421 (Electronic) Linking ISSN: 01655728 NLM ISO Abbreviation: J Neuroimmunol Subsets: MEDLINE

مواضيع طبية MeSH: Immunoglobulin G* , Myasthenia Gravis*, Humans ; Autoantibodies

المؤلفون: Ruiter AM; Department of Neurology, Leiden University Medical Center, the Netherlands. Electronic address: a.m.ruiter@lumc.nl., Strijbos E; Department of Neurology, Leiden University Medical Center, the Netherlands., de Meel RHP; Department of Neurology, Leiden University Medical Center, the Netherlands., Lipka AF; Department of Neurology, Leiden University Medical Center, the Netherlands; Department of Neurology, Groene Hart Hospital, Gouda, the Netherlands., Raadsheer WF; Department of Neurology, Leiden University Medical Center, the Netherlands., Tannemaat MR; Department of Neurology, Leiden University Medical Center, the Netherlands., Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, the Netherlands.

المصدر: Neuromuscular disorders : NMD [Neuromuscul Disord] 2021 Jul; Vol. 31 (7), pp. 622-632. Date of Electronic Publication: 2021 May 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 9111470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2364 (Electronic) Linking ISSN: 09608966 NLM ISO Abbreviation: Neuromuscul Disord Subsets: MEDLINE

مواضيع طبية MeSH: Myasthenia Gravis/*epidemiology, Adult ; Aged ; Antibodies ; Cost of Illness ; Female ; Humans ; Lambert-Eaton Myasthenic Syndrome/epidemiology ; Male ; Middle Aged ; Netherlands/epidemiology ; Patient Reported Outcome Measures ; Quality of Life ; Registries

المؤلفون: Lipka AF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Groene Hart Hospital, Gouda, The Netherlands., Titulaer MJ; Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands., Tannemaat MR; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Muscle & nerve [Muscle Nerve] 2020 Jul; Vol. 62 (1), pp. 111-114. Date of Electronic Publication: 2020 Apr 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 7803146 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4598 (Electronic) Linking ISSN: 0148639X NLM ISO Abbreviation: Muscle Nerve Subsets: MEDLINE

مواضيع طبية MeSH: Electrodiagnosis/*methods , Electrodiagnosis/*standards , Lambert-Eaton Myasthenic Syndrome/*diagnosis , Lambert-Eaton Myasthenic Syndrome/*physiopathology, Action Potentials/physiology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Muscle Weakness/diagnosis ; Muscle Weakness/physiopathology ; Reflex, Stretch/physiology ; Retrospective Studies ; Young Adult

المؤلفون: Maddison P; Department of Neurology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, NG7 2UH, UK. paul.maddison@nhs.net., Lipka AF; Department of Neurology, Groene Hart Hospital, Gouda, The Netherlands.; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands., Gozzard P; Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK., Sadalage G; Division of Neurology, Queens Medical Centre, University of Nottingham, Nottingham University Hospitals NHS Trust, Nottingham, UK., Ambrose PA; Division of Neurology, Queens Medical Centre, University of Nottingham, Nottingham University Hospitals NHS Trust, Nottingham, UK., Lang B; Nuffield Department of Clinical Neurosciences, University of Oxford, West Wing, John Radcliffe Hospital, Oxford, OX3 9DS, UK., Verschuuren JJ; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

المصدر: Scientific reports [Sci Rep] 2020 Jun 29; Vol. 10 (1), pp. 10546. Date of Electronic Publication: 2020 Jun 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Lambert-Eaton Myasthenic Syndrome/*complications , Lung Neoplasms/*diagnosis , Small Cell Lung Carcinoma/*diagnosis, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Early Detection of Cancer ; Female ; Humans ; Lung Neoplasms/etiology ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Small Cell Lung Carcinoma/etiology ; Young Adult

المؤلفون: Lipka AF; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway. a.f.lipka@lumc.nl., Boldingh MI; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway., van Zwet EW; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway., Schreurs MWJ; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway., Kuks JBM; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway., Tallaksen CM; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway., Titulaer MJ; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway., Verschuuren JJGM; From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway.

المصدر: Neurology [Neurology] 2020 Feb 04; Vol. 94 (5), pp. e511-e520. Date of Electronic Publication: 2019 Dec 12.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Lambert-Eaton Myasthenic Syndrome/*physiopathology , Lung Neoplasms/*mortality , Small Cell Lung Carcinoma/*mortality, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Case-Control Studies ; Female ; Humans ; Immunosuppressive Agents ; Lambert-Eaton Myasthenic Syndrome/complications ; Lambert-Eaton Myasthenic Syndrome/immunology ; Lambert-Eaton Myasthenic Syndrome/therapy ; Lung Neoplasms/complications ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Neoplasm Staging ; Netherlands ; Plasma Exchange ; Small Cell Lung Carcinoma/complications ; Small Cell Lung Carcinoma/therapy ; Survival Rate ; Young Adult

المؤلفون: de Wilde S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: s.de_wilde@lumc.nl., de Jong MGH; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. Electronic address: m.g.h.dejong@students.uu.nl., Lipka AF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.f.lipka@lumc.nl., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: h.j.guchelaar@lumc.nl., Schimmel KJM; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: k.j.m.schimmel@lumc.nl.

المصدر: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2018 Mar 01; Vol. 114, pp. 24-29. Date of Electronic Publication: 2017 Nov 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

مواضيع طبية MeSH: 4-Aminopyridine/*analogs & derivatives , Drug Compounding/*methods , Lambert-Eaton Myasthenic Syndrome/*drug therapy , Marketing/*methods , Orphan Drug Production/*methods, 4-Aminopyridine/economics ; 4-Aminopyridine/therapeutic use ; Amifampridine ; Direct-to-Consumer Advertising/economics ; Direct-to-Consumer Advertising/legislation & jurisprudence ; Direct-to-Consumer Advertising/methods ; Drug Compounding/economics ; Humans ; Lambert-Eaton Myasthenic Syndrome/economics ; Marketing/economics ; Marketing/legislation & jurisprudence ; Orphan Drug Production/economics ; Orphan Drug Production/legislation & jurisprudence ; Potassium Channel Blockers/economics ; Potassium Channel Blockers/therapeutic use ; Qualitative Research ; Retrospective Studies

المؤلفون: De Meel RHP; Department of Neurology, Leiden University Medical Center, J3-166, P.O. Box 9600, 2300, RC Leiden, The Netherlands., Lipka AF; Department of Neurology, Leiden University Medical Center, J3-166, P.O. Box 9600, 2300, RC Leiden, The Netherlands., Van Der Lende M; Department of Neurology, Leiden University Medical Center, J3-166, P.O. Box 9600, 2300, RC Leiden, The Netherlands., Van Zwet EW; Department of Biostatistics, Leiden University Medical Center, Leiden, The Netherlands., Tannemaat MR; Department of Neurology, Leiden University Medical Center, J3-166, P.O. Box 9600, 2300, RC Leiden, The Netherlands., Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, J3-166, P.O. Box 9600, 2300, RC Leiden, The Netherlands.

المصدر: Muscle & nerve [Muscle Nerve] 2017 Jul; Vol. 56 (1), pp. 64-70. Date of Electronic Publication: 2016 Dec 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 7803146 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4598 (Electronic) Linking ISSN: 0148639X NLM ISO Abbreviation: Muscle Nerve Subsets: MEDLINE

مواضيع طبية MeSH: Disability Evaluation*, Muscle Weakness/*etiology , Myasthenia Gravis/*complications, Adult ; Age Factors ; Aged ; Autoantibodies/blood ; Female ; Humans ; Male ; Middle Aged ; Muscle Weakness/diagnosis ; Myasthenia Gravis/blood ; Myasthenia Gravis/immunology ; Receptor Protein-Tyrosine Kinases/immunology ; Receptors, Cholinergic/immunology ; Retrospective Studies ; Statistics as Topic

المؤلفون: Weinreich SS; Department of Clinical Genetics, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands. s.weinreich@vumc.nl.; Department of Care, National Health Care Institute, Diemen, The Netherlands. s.weinreich@vumc.nl., Vrinten C; Department of Clinical Genetics, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.; Department of Epidemiology and Public Health, University College London, London, UK., Kuijpers MR; Department of Care, National Health Care Institute, Diemen, The Netherlands., Lipka AF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Schimmel KJM; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., van Zwet EW; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands., Gispen-de Wied C; Medicines Evaluation Board, Utrecht, The Netherlands., Hekster YA; Medicines Evaluation Board, Utrecht, The Netherlands., Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Cornel MC; Department of Clinical Genetics, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.

المصدر: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2017 May 12; Vol. 12 (1), pp. 88. Date of Electronic Publication: 2017 May 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE

مواضيع طبية MeSH: Ephedrine/*metabolism , Myasthenia Gravis/*metabolism , Rare Diseases/*metabolism, Humans ; Myasthenia Gravis/pathology ; Outcome Assessment, Health Care ; Precision Medicine ; Rare Diseases/pathology ; Retrospective Studies

المؤلفون: Lipka AF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.f.lipka@lumc.nl., Vrinten C; Department of Clinical Genetics and EMGO Institute for Health and Care Research, section Community Genetics & Public Health Genomics, VU University Medical Center, Amsterdam, The Netherlands; Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London, United Kingdom., van Zwet EW; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands., Schimmel KJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Cornel MC; Department of Clinical Genetics and EMGO Institute for Health and Care Research, section Community Genetics & Public Health Genomics, VU University Medical Center, Amsterdam, The Netherlands., Kuijpers MR; Department of Care, Section Pharmaceutical Care, National Health Care Institute, Diemen, The Netherlands., Hekster YA; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands., Weinreich SS; Department of Clinical Genetics and EMGO Institute for Health and Care Research, section Community Genetics & Public Health Genomics, VU University Medical Center, Amsterdam, The Netherlands., Verschuuren JJ; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Neuromuscular disorders : NMD [Neuromuscul Disord] 2017 Mar; Vol. 27 (3), pp. 259-265. Date of Electronic Publication: 2016 Nov 18.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 9111470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2364 (Electronic) Linking ISSN: 09608966 NLM ISO Abbreviation: Neuromuscul Disord Subsets: MEDLINE

مواضيع طبية MeSH: Outcome Assessment, Health Care*, Ephedrine/*pharmacology , Immunosuppressive Agents/*therapeutic use , Myasthenia Gravis/*drug therapy , Receptors, Cholinergic/*immunology , Sympathomimetics/*pharmacology, Adult ; Autoantibodies/blood ; Cross-Over Studies ; Double-Blind Method ; Drug Therapy, Combination ; Ephedrine/administration & dosage ; Ephedrine/adverse effects ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Middle Aged ; Myasthenia Gravis/immunology ; Sympathomimetics/administration & dosage ; Sympathomimetics/adverse effects